Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. - Wikidata - awgldk - TriplyDB

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

http://www.wikidata.org/entity/Q30487807

about

Epidemiology of cervical cancer in Latin America Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta.A Suggested Approach to Simplify and Improve Cervical Screening in the United States.Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening.Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.Primary HPV testing verification: A retrospective ad-hoc analysis of screening algorithms on women doubly tested for cytology and HPV.Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.Prevalence of High-Risk Human Papillomavirus Infection in China: Analysis of 671,163 Human Papillomavirus Test Results From China's Largest College of American Pathologists-Certified Laboratory.Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.Reply to Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?The clinical performance of computer-assisted liquid-based cytology, primary hrHPV screening, and cotesting at a Turkish Tertiary Care Hospital.Reply to why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.Cytomorphology of Gastric-Type Cervical Adenocarcinoma on a ThinPrep Pap Test: Report of a p16-Positive Tumor Case.Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.A Large Retrospective Study of 12714 Cases of LEEP Conization Focusing on Cervical Cancer That Colposcopy-Directed Biopsy Failed to Detect.

P2860

Q26777712-A80C376B-6B3F-4130-BB2E-3AE92980481D Q30239987-BF58890F-A2A1-4E5F-812A-06A88483C5E4 Q30276085-17FAB254-6AC2-4CF6-8551-EFB1DFD32DC3 Q33853760-F1D266F8-F4A3-4C10-8456-9B24CBFFFB9B Q35870574-3D66579D-A468-461B-B81D-37BA152EF6AC Q36165724-C2FDE379-0F11-4C8C-BCD6-09B8C7AC0909 Q36407125-62B88DB8-0AAA-49B0-9197-5F7E6A7A8AC4 Q36679762-50A84534-5F5F-4EDF-BF0F-AF7DFE77479B Q36728773-774A5A5D-0FF8-4269-BD20-C3558A694DBD Q36987575-1068B2F2-6A00-485C-B961-4E6080A5829E Q38740197-C916BB06-F4F2-4F84-82A4-110194C13C18 Q38744571-6F59464A-AC70-4C30-967E-F6C5BF1D4871 Q38752133-A66CD949-261F-4BD9-91E4-D893F0F86EBF Q38785689-F118167D-8F75-413D-8C53-C3C8533772FF Q38789321-315082FF-69AA-4887-9C77-7796DA3C00B9 Q38823664-AADB3690-DF53-46E0-BB08-DB6D6887CA6E Q40101106-0BDAB93B-9978-49CF-A062-0C2F6758D854 Q40695267-449A9115-66C7-4B0D-82B4-81E7378DD5B7 Q40861259-ADA7CE4F-A96F-4C80-A9FD-ACC129D18726 Q41037128-5740C15C-70A8-4F2F-BABB-313429AB8EF5 Q42391616-C0B307E2-5361-4A84-83C8-9D2070594A1A Q43547415-61FCFD8F-6EA1-47E0-B8D5-94A08E427372 Q46702041-E83121C6-39DC-4B85-9CB4-905078F77CBD Q47572365-24606163-A381-446A-9652-89D75218E282 Q47669409-703CFF85-20BC-4C56-BB19-02AA9B7CB7B1 Q48198042-44A3B2D5-3B95-4AC5-B6AD-BD76F2EAB9B3 Q50965976-1EFA7ED9-4E7E-4FDC-A08C-C0959F668739 Q53104036-9C546764-DA9F-463B-BF2A-ABDBEDE8E6EA Q53698646-E1FF49E6-D93E-46A0-966C-BDACEA989569 Q55275772-3C238C25-84B3-4366-938D-5C40E6779028

P2860

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

http://www.wikidata.org/entity/Q30487807

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Comparison of cervical cancer ...... n multiple clinical practices.

@ast

Comparison of cervical cancer ...... n multiple clinical practices.

@en

type

label

Comparison of cervical cancer ...... n multiple clinical practices.

@ast

Comparison of cervical cancer ...... n multiple clinical practices.

@en

prefLabel

Comparison of cervical cancer ...... n multiple clinical practices.

@ast

Comparison of cervical cancer ...... n multiple clinical practices.

@en

P1433

Q30487807-2521E5A0-543B-4B0E-936A-1BDDDD9C7520

P1476

Q30487807-E2D518E0-D0BA-4759-8874-6BF8510A4751

P2093

Q30487807-472AFAE8-8E81-4A04-9DF9-74679D09D52C

Q30487807-65A4561B-AD1B-4D5A-A30B-334F7ABBFCF3

Q30487807-85BB999F-4B83-4958-B9C8-7789122032BE

Q30487807-889D8A81-684E-40F9-9C3F-BC7A22F836CC

Q30487807-FF7293FB-2967-4904-A278-2A12F8B4DF92

P2860

Q30487807-017C10AC-2A7B-4983-AAF7-CE78DAA6DDB6

Q30487807-0EC82AD4-2EDD-411A-9FC1-F1D0B788DB06

Q30487807-12967FEE-79A6-4896-B359-841C69A7F1ED

Q30487807-206DCEF0-7977-4895-989F-262A0467BBA0

Q30487807-2C30457C-9301-49B7-8868-48E58ADA7A74

Q30487807-33B696BE-D31B-4B45-B1F6-BD5C9D3EF7E2

Q30487807-341F3DB3-7E6E-41B6-A959-2C277FD4947E

Q30487807-35B0F8A3-51EF-4F68-86AB-9BA6F0CCE142

Q30487807-3832FD08-5465-484F-9664-4B9788678974

Q30487807-3AFEC326-9E65-4571-B1CA-00EE4C468E10

P304

Q30487807-736B45EE-8FB5-47E4-AE1E-755CF92ADD1B

P31

Q30487807-AFEE1A0E-F45F-4A83-AB8C-D168D61DBC36

P356

Q30487807-EA24137B-5946-402A-AB19-04BEE7A00002

P433

Q30487807-CD356A89-5B02-46CB-9481-81E6CE67A07A

P478

Q30487807-AEF7C7D6-ED03-4501-8677-D704B1B30619

P577

Q30487807-34857F7B-76BD-4558-B72F-DA573AC38469

P5875

Q30487807-1923359B-6E2C-416B-9F22-524D23A1B3D4

P698

Q30487807-CE12405B-E722-49D2-A6DF-0DEF6961D889

P932

Q30487807-0133733B-D6CA-4D9C-B8AB-2C7B49E1DA4F

P356

P1433

Cancer Cytopathology

P1476

Comparison of cervical cancer ...... n multiple clinical practices.

@en

P2093

Amy J Blatt

http://www.w3.org/2001/XMLSchema#string

Douglas S Rabin

http://www.w3.org/2001/XMLSchema#string

R Marshall Austin

http://www.w3.org/2001/XMLSchema#string

Ronald D Luff

http://www.w3.org/2001/XMLSchema#string

Ronald Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

ACOG Practice Bulletin Number 131: Screening for cervical cancer.

Co-testing for detection of high-grade cervical intraepithelial neoplasia and cancer compared with cytology alone: a meta-analysis of randomized controlled trials.

Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.

Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.

P304

282-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCY.21544

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274902050

http://www.w3.org/2001/XMLSchema#string

P698

25864682

http://www.w3.org/2001/XMLSchema#string

P932

4654274

http://www.w3.org/2001/XMLSchema#string